Neuromodulation trials

Clinical Study on a Novel Strategy of Individualized Non-Invasive Neuromodulation for the Treatment of Tic Disorders in

RecruitingNCT07351955Phase: NAStarted 2025-06-01

Summary

This study aims to establish a novel personalized closed-loop NiBS/TMS therapeutic strategy and clinical protocol for children with Tic Disorders (TDs) through a series of scientific investigations. A

Eligibility

Sex
ALL
Min Age
5 Months
Max Age
18 Years

Locations

Shanghai Children's Medical Center,School of Medicine, ShangShanghai, Shanghai Municipality, China

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT07351955